Literature DB >> 23893448

Psychiatric comorbidities in dystonia: emerging concepts.

Mateusz Zurowski1, William M McDonald, Susan Fox, Laura Marsh.   

Abstract

Psychiatric disorders are highly prevalent in patients with dystonia and have a profound effect on quality of life. Patients with dystonia frequently meet criteria for anxiety disorders, especially social phobia, and major depressive disorder. Deficits in emotional processing have also been demonstrated in some dystonia populations. Onset of psychiatric disturbances in patients with dystonia often precedes onset of motor symptoms, suggesting that the pathophysiology of dystonia itself contributes to the genesis of psychiatric disturbances. This article examines the hypothesis that mood and anxiety disorders are intrinsic to the neurobiology of dystonia, citing the available literature, which is derived mostly from research on focal isolated dystonias. Limitations of studies are identified, and the role of emotional reactivity, especially in the context of pain secondary to dystonia, is recognized. Available evidence underscores the need to develop dystonia assessment tools that incorporate psychiatric measures. Such tools would allow for a better understanding of the full spectrum of dystonia presentations and facilitate research on the treatment of dystonia as well as the treatment of psychiatric illnesses in the context of dystonia. This article, solicited for a special Movement Disorders issue on novel research findings and emerging concepts in dystonia, addresses the following issues: (1) To what extent are psychiatric disturbances related to the pathophysiology of dystonia? (2) What is the impact of psychiatric disturbances on outcome measures of current assessment tools for dystonia? (3) How do psychiatric comorbidities influence the treatment of dystonia? Answers to these questions will lead to an increased appreciation of psychiatric disorders in dystonia, a better understanding of brain physiology, more nuanced research questions pertaining to this population, better clinical scales that can be used to further patient management and research, and improved patient outcomes.
© 2013 Movement Disorder Society. © 2013 Movement Disorder Society.

Entities:  

Keywords:  anxiety; depression; dystonia; psychiatry; social phobia

Mesh:

Year:  2013        PMID: 23893448      PMCID: PMC3842100          DOI: 10.1002/mds.25501

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  43 in total

1.  Obsessive-compulsive symptoms in primary focal dystonia: a controlled study.

Authors:  Bernardo Barahona-Corrêa; Paulo Bugalho; João Guimarães; Miguel Xavier
Journal:  Mov Disord       Date:  2011-08-09       Impact factor: 10.338

2.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

3.  Musician's dystonia and comorbid anxiety: two sides of one coin?

Authors:  Leonie Enders; June T Spector; Eckart Altenmüller; Alexander Schmidt; Christine Klein; Hans-Christian Jabusch
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

4.  The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia).

Authors:  C D Marsden
Journal:  Adv Neurol       Date:  1976

Review 5.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

6.  Idiopathic cervical dystonia: clinical characteristics.

Authors:  J Chan; M F Brin; S Fahn
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

7.  Psychological functioning before and after treatment of torticollis with botulinum toxin.

Authors:  M Jahanshahi; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.

Authors:  G A Heiman; R Ottman; R J Saunders-Pullman; L J Ozelius; N J Risch; S B Bressman
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

9.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

10.  Psychiatric comorbidity in patients with spasmodic torticollis.

Authors:  T Wenzel; P Schnider; A Wimmer; N Steinhoff; E Moraru; E Auff
Journal:  J Psychosom Res       Date:  1998-06       Impact factor: 3.006

View more
  31 in total

1.  Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease.

Authors:  Susanne Steinlechner; Johann Hagenah; Hans-Jürgen Rumpf; Christian Meyer; Ulrich John; Tobias Bäumer; Norbert Brüggemann; Meike Kasten; Alexander Münchau; Christine Klein; Rebekka Lencer
Journal:  J Neurol       Date:  2017-04-11       Impact factor: 4.849

Review 2.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 3.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

4.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

5.  The role of the trigeminal sensory nuclear complex in the pathophysiology of craniocervical dystonia.

Authors:  Lynley Bradnam; Christine Barry
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

6.  Cervical dystonia and substance abuse.

Authors:  Abhimanyu Mahajan; Joseph Jankovic; Laura Marsh; Achint Patel; H A Jinnah; Cynthia Comella; Richard Barbano; Joel Perlmutter; Neepa Patel
Journal:  J Neurol       Date:  2018-03-22       Impact factor: 4.849

Review 7.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

8.  The dystonias: past, present, and future.

Authors:  H A Jinnah; Mahlon R Delong; Mark Hallett
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 9.  Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

Authors:  H A Jinnah; Cynthia L Comella; Joel Perlmutter; Codrin Lungu; Mark Hallett
Journal:  Toxicon       Date:  2017-09-06       Impact factor: 3.033

10.  Fatigue, Sleep Disturbances, and Their Influence on Quality of Life in Cervical Dystonia Patients.

Authors:  Marenka Smit; Arwen S J Kamphuis; Anna L Bartels; Vladimir Han; Roy E Stewart; Inge Zijdewind; Marina A Tijssen
Journal:  Mov Disord Clin Pract       Date:  2016-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.